LXEO
NASDAQStockLexeo Therapeutics, Inc. Common Stock
$6.54-0.09 (-1.36%)
52-Week Range
$1.79
$10.63
Key Stats
Market Cap
477.3M
P/E Ratio
—
Dividend Yield
—
Beta
1.80
Volume
1.1M
Avg Volume
816.9K
Performance
1M
+0.91%
3M
-32.07%
6M
+23.23%
YTD
-31.01%
1Y
+115.96%
3Y
-34.03%
5Y
-34.03%
Price Chart
ETF Exposure
LXEO is held by 70 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.56% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.53% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.31% |
| CURE.AX | Global X - S&P Biotech ETF | 0.15% |
| XBI | State Street SPDR S&P Biotech ETF | 0.14% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.11% |
| IWC | iShares Micro-Cap ETF | 0.09% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.09% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.07% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.04% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| PWS | Pacer WealthShield ETF | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.01% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFSU | Dimensional - US Sustainability Core 1 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
Page 1 of 2Next
About LXEO ETF Exposure
Lexeo Therapeutics, Inc. Common Stock (LXEO) is held by 70 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 477.3M, LXEO is a widely held institutional stock. The stock currently trades at $6.54. Investors can gain exposure to LXEO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LXEO, sorted by portfolio weight.